143 related articles for article (PubMed ID: 3910595)
1. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
Hua LA; Kagen CN; Carpenter RJ; Goltz RW
Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of HLA heavy chain and light chain (beta 2 microglobulin) expression on the cell surface of cutaneous malignancies.
Mauduit G; Turbitt M; MacKie RM
Br J Dermatol; 1983 Oct; 109(4):377-81. PubMed ID: 6414503
[TBL] [Abstract][Full Text] [Related]
3. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
5. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
6. Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies.
Holden CA; Sanderson AR; MacDonald DM
J Am Acad Dermatol; 1983 Dec; 9(6):867-71. PubMed ID: 6196384
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
8. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
9. Beta-2-microglobulin in basal cell carcinoma.
Tjernlund UM; Forsum U
Acta Derm Venereol; 1977; 57(6):503-6. PubMed ID: 73324
[TBL] [Abstract][Full Text] [Related]
10. Absence of HLA class I and class II antigens as well as beta 2-microglobulin from normal and pathological human spermatozoa.
Kuhlmann D; Dohr G; Pusch HH; Scherbaum W; Schieferstein G; Uchańska-Ziegler B; Ziegler A
Tissue Antigens; 1986 Mar; 27(3):179-84. PubMed ID: 2424141
[TBL] [Abstract][Full Text] [Related]
11. HLA molecules in basal cell carcinoma of the skin.
Cabrera T; Garrido V; Concha A; Martín J; Esquivias J; Oliva MR; Ruiz-Cabello F; Serrano S; Garrido F
Immunobiology; 1992 Sep; 185(5):440-52. PubMed ID: 1452215
[TBL] [Abstract][Full Text] [Related]
12. beta-2-microglobulin in benign and malignant adnexal skin tumors and metastasizing basocellular carcinomas.
Kallioinen M; Dammert K
J Cutan Pathol; 1984 Feb; 11(1):27-34. PubMed ID: 6365986
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte class I antigen and beta2-microglobulin expression in conjunctival dysplasia, carcinoma in situ, and squamous cell carcinoma.
Krishnakumar S; Lakshmi SA; Pusphparaj V; Iyer A; Abhyankar D; Biswas J
Cornea; 2005 Apr; 24(3):337-41. PubMed ID: 15778609
[TBL] [Abstract][Full Text] [Related]
14. The presence of beta2 microglobulin on the membrane of the keratinocyte in premalignant skin disorders.
Vinninghe HR; Neumann HA
Br J Dermatol; 1981 May; 104(5):515-9. PubMed ID: 6165373
[TBL] [Abstract][Full Text] [Related]
15. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
17. HLA molecule expression in cutaneous squamous cell carcinomas: an immunopathological study and clinical-immunohistopathological correlations.
García-Plata D; Mozos E; Carrasco L; Solana R
Histol Histopathol; 1993 Apr; 8(2):219-26. PubMed ID: 7683937
[TBL] [Abstract][Full Text] [Related]
18. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
[TBL] [Abstract][Full Text] [Related]
19. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
20. Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.
Nissen MH; Larsen JK; Plesner T; Olesen BK; Ernst P
Clin Exp Immunol; 1987 Sep; 69(3):632-8. PubMed ID: 2959413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
